Adherium Limited (ASX: ADR) Share Price Click here
Adherium Limited (ASX: ADR) is a provider of digital health solutions and a global leader in connected respiratory medical devices, with more than 170,000 sold globally. The Company develops, manufactures and supplies a broad range of connected medical devices for respiratory medications for patients, pharmaceutical companies, healthcare providers and contract research organisations.
Adherium’s Hailie solution is designed to help patients achieve better adherence and provide visibility to parents and caregivers. It does this by tracking medication use and reminding the user with helpful nudges when it is time to take doses, and by providing access to usage history to better understand patterns in their asthma and COPD.
Adherium has a series of new asthma and COPD sensors in development which, with their existing capabilities, will also enable the capture of physiological measures enabling access to CPT reimbursement for remote patient monitoring in the US.
These tools ultimately enable patients, with their physicians, to more effectively manage their Asthma and COPD and at the same time as potentially deliver significant healthcare cost savings to payors and providers. www.adherium.com
Rick Legleiter appointed Chief Executive Officer of Adherium Limited
Adherium Limited CEO Rick Legleiter resigns
Rick Legleiter appointed Chief Executive Officer of Adherium Limited